Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GSK 4069327A

Next Previous
Drug Profile

GSK 4069327A

Alternative Names: Flexyn2a; GSK-4069327A; GVXN-SD133; S4V2; Shigella 4V; Shigella dysenteriae bioconjugate vaccine - GlycoVaxyn; Shigella flexneri 2a vaccine - GlycoVaxyn; Shigella vaccine - LimmaTech Biologics; Shigella-4V2

Latest Information Update: 21 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlycoVaxyn
  • Developer GlycoVaxyn; Johns Hopkins Bloomberg School of Public Health; LimmaTech Biologics
  • Class Bacterial vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Shigella infections

Most Recent Events

  • 09 Apr 2025 LimmaTech Biologics plans a phase III trial for Shigella-infections
  • 07 Apr 2025 LimmaTech Biologics initiates a phase-II trial in Shigella infections (In infants, Prevention) in Kenya (IM) (NCT06523231)
  • 20 Mar 2025 LimmaTech plans phase II paediatric study in Low and middle income countries (LMIC) in the first half of 2025

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top